9 employees
At GLX Analytix, we combine a new, proprietary class of blood biomarker with AI to bring personalized medicine to your healthcare.
2019
GLX Analytix raised undisclosed on June 14, 2022
Investors: CBC Investment Group AB and DigitalDx Ventures